Biotherapeutics company MediWound has secured an additional $6.7 million in funding from the US Department of Defense to advance its non-surgical burn treatment for the US Army.
1. The current randomized controlled trial is the first of its kind to demonstrate the efficacy of maggot debridement therapy (MDT) for full-thickness burns compared to the standard of care (silver dressings). 2. Time to debridement and time to full healing were both improved in the MDT group, and this finding was even more pronounced
R&D project budget increased to $6.5Million to advance NexoBrid as a non-surgical field care solutionYAVNE, Israel, Sept. 26, 2023 (GLOBE NEWSWIRE) MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), has awarded MediWound additional funding to develop NexoBrid® as a non-surgical solu
Forecasters say the clouds will start rolling in later this afternoon and becoming more prominent this evening with a 60 per cent chance of showers overnight and into tomorrow morning.